CalciMedica, Inc.CALCNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | -3258.62% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | -3978.46% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | -2806.77% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | -2890.70% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +122.31% | +44.77% | +34.74% | +34.67% | +117538.55% |
| Weighted Average Shares Diluted Growth | +122.31% | +40.55% | +34.74% | +34.67% | +117538.55% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +62.45% | -6.59% | -9.37% | -8.01% | -31.34% |
| Book Value per Share Growth | -20.53% | -56.39% | -67.27% | +0.00% | +0.00% |
| Debt Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | +37.71% | +43.48% | -2.53% | +8.60% | -18.90% |
| SG&A Expenses Growth | +51.40% | -19.48% | +8.31% | -19.32% | -45.08% |